Physician

Michel Shami, M.D.

According to 2025 Medicare claims, Michel Shami, M.D. (NPI: 1780683227) practices ophthalmology in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is TEXAS RETINA ASSOCIATES (NPI: 1093750853; TIN: 751362336) and primary practice location at 79424-5013.

Shami's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,109 traditional Medicare patients, billed 39,467 HCPCS/CPT codes, and received $2,119,896 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 1,041 prescription claims across 307 beneficiaries totaling $53,988 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 10 records totaling $195. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,012,249 to $2,119,896. In contrast, Part D prescription costs have declined steadily, from $112,285 to $53,988. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.1M2015 Medicare payment: $1,012,249 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $819,634 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,159,802 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,282,340 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,452,956 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,373,814 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,403,968 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,577,115 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,996,287 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,119,896 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,83311,285$1,012,249
20161,3018,633$819,634
20171,2079,654$1,159,802
20181,18411,481$1,282,340
20191,13110,487$1,452,956
20201,1409,416$1,373,814
20211,1619,222$1,403,968
20221,11913,780$1,577,115
20231,14128,337$1,996,287
20241,10939,467$2,119,896

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$56K$112K2015 Drug cost: $112,285 (USD; Tot_Drug_Cst)2016 Drug cost: $93,157 (USD; Tot_Drug_Cst)2017 Drug cost: $86,224 (USD; Tot_Drug_Cst)2018 Drug cost: $81,709 (USD; Tot_Drug_Cst)2019 Drug cost: $92,146 (USD; Tot_Drug_Cst)2020 Drug cost: $79,552 (USD; Tot_Drug_Cst)2021 Drug cost: $78,891 (USD; Tot_Drug_Cst)2022 Drug cost: $67,264 (USD; Tot_Drug_Cst)2023 Drug cost: $63,247 (USD; Tot_Drug_Cst)2024 Drug cost: $53,988 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015226917$112,285
2016179732$93,157
2017194714$86,224
2018223713$81,709
2019217815$92,146
2020231881$79,552
2021263978$78,891
20222801,149$67,264
2023278967$63,247
20243071,041$53,988

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system262262$107
67028Injection of drug into eye3561,107$90
92014Established patient complete exam of visual system626867$87
92012Established patient problem focused exam of visual system322511$62
92134Imaging of retina1,0762,699$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium251,439$9,455
Prednisolone AcetatePrednisolone Acetate1395,855$6,469
Bromfenac SodiumBromfenac Sodium331,211$4,821
Dorzolamide HclDorzolamide Hcl22713,392$4,771
Tobramycin-DexamethasoneTobramycin/Dexamethasone1112,410$4,580

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$195Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michel Shami, M.D.?

Tedicare shows public-source Medicare data for Michel Shami, M.D. (NPI 1780683227), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michel Shami, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michel Shami, M.D.?

Michel Shami, M.D. is linked to TEXAS RETINA ASSOCIATES (billing NPI 1093750853) in the available physician profile data.

Does Michel Shami, M.D. have Open Payments data?

Michel Shami, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.